Pharmaceutical

Filter

Current filters:

None

Popular Filters

1 to 25 of 7074 results

Horizon Pharma buys US rights to Nuvo’s Pennsaid for $45 million

19-10-2014

Canadian specialty drugmaker Nuvo Research says it has completed the sale of its osteoarthritis pain…

Anti-Arthritics/RheumaticsHorizon PharmaLicensingMallinckrodtNuvo ResearchPennsaidPharmaceuticalUSA

Indian government takes action on country’s growing mental health problems

18-10-2014

Stigma, ignorance and a severe lack of doctors in India have long marred mental health care projects…

Human InterestIndiaNeurologicalPharmaceutical

GSK Ebola vaccine “too late” for current Ebola outbreak; more on Ebola

17-10-2014

UK pharma giant GlaxoSmithKline says any Ebola vaccine it produces will come too late for the current…

Anti-viralsAVI-6002GlaxoSmithKlinePharmaceuticalProductionResearchSarepta Therapeutics

Pharmacyclics’ Imbruvica gains EU approval for two blood cancers

17-10-2014

US drugmaker Pharmacyclics has received marketing approval from the European Commission for Imbruvica…

EuropeImbruvicaJohnson & JohnsonOncologyPharmaceuticalPharmacyclicsRegulation

New WikiLeaks revelations on Trans-Pacific Trade Pact Text

17-10-2014

Access to affordable cancer treatments in the USA and 11 other countries would be delayed for years if…

Asia-PacificPatents & Trade marksPharmaceuticalPoliticsUSA

Pharmacyclics and Roche research Imbruvica and Gazyva

Pharmacyclics and Roche research Imbruvica and Gazyva

17-10-2014

USA-based biopharma company Pharmacyclics has entered into a master clinical drug supply agreement with…

GazyvaImbruvicaOncologyPharmaceuticalPharmacyclicsResearchRocheUSA

ACCC proposes to strengthen new individual reporting in Australian pharmaceutical code

17-10-2014

The Australian Competition and Consumer Commission (ACCC) is proposing to grant conditional authorization…

AustraliaMarkets & MarketingPharmaceuticalRegulation

US FDA panel votes to keep Chantix black box warning; staffers recommend secukinumab

US FDA panel votes to keep Chantix black box warning; staffers recommend secukinumab

17-10-2014

The US Food and Drug Administration's advisory panel has voted to keep a black box warning on US pharma…

ChantixNovartisPfizerPharmaceuticalRegulationsecukinumabUSA

NICE reverses guidance on Novartis’ Glivec for GIST

NICE reverses guidance on Novartis’ Glivec for GIST

17-10-2014

UK health costs watchdog the National Institute for Health and Care Excellence (NICE) has issued new…

GlivecNovartisOncologyPharmaceuticalPricingRegulationUK

Supply chain pressure can pose serious risk to pharma, experts argue

Supply chain pressure can pose serious risk to pharma, experts argue

16-10-2014

CPhI Worldwide, part of UBM Live’s Pharmaceutical Portfolio, has released the final part of its 2014…

BiotechnologyCPhI WorldwideGlobalPharmaceuticalResearch

Sanofi Pasteur and Immune Design announce herpes vaccine collaboration

Sanofi Pasteur and Immune Design announce herpes vaccine collaboration

16-10-2014

Sanofi Pasteur, the vaccines division of French drug major Sanofi, and Immune Design, a clinical-stage…

FranceImmune DesignPharmaceuticalResearchSanofi PasteurVaccines

Cosmo Pharma plans to move management seat to Ireland

16-10-2014

Recently jilted Italian drugmaker Cosmo Pharmaceuticals says that its board of directors has resolved…

Cosmo PharmaceuticalsIrelandManagementMergers & AcquisitionsPharmaceuticalProductionSalix Pharmaceuticals

Baxter third-qtr earnings hit by costs, but sales rise

16-10-2014

US health care product company Baxter International today reported a 14% drop in net income of $468 million…

Baxter InternationalFinancialPharmaceutical

Neuroscience a key feature of AstraZeneca’s collaboration with University of Cambridge

Neuroscience a key feature of AstraZeneca’s collaboration with University of Cambridge

16-10-2014

Anglo-Swedish drug major AstraZeneca, together with its global biologics R&D arm MedImmune, has entered…

AstraZenecaNeurologicalPharmaceuticalResearchUK

FDA FOCUS: The medical marijuana controversy

FDA FOCUS: The medical marijuana controversy

16-10-2014

In the third of a monthly FDA-focused blog published exclusively by The Pharma Letter, Dr Nicola Davies…

MarinolPharmaceuticalRegulationUnited StatesUSA

Strong new data for Novartis’ investigational leukemia drug CTL019

16-10-2014

Swiss pharma giant Novartis and the US University of Pennsylvania's Perelman School of Medicine (Penn)…

CTL019NovartisOncologyPharmaceuticalResearch

ISPE unveils plan to prevent drug shortages

16-10-2014

Regulators from the European Medicines, the US Food and Drug Administration and the UK’s Medicines…

GlobalMarkets & MarketingPharmaceuticalProductionRegulation

Pfizer looks set to win $100 million Russian vaccines contract

16-10-2014

The Swiss unit of US pharma giant Pfizer has remained the only bidder for the 3.47 billion-rouble ($100…

GlaxoSmithKlineMarkets & MarketingPfizerPharmaceuticalPrevenarRussiaSynflorixVaccines

Rheumatologists welcome novel biologics for systemic lupus erythematosus, survey finds

Rheumatologists welcome novel biologics for systemic lupus erythematosus, survey finds

16-10-2014

Rheumatologists would welcome novel biologics for the treatment of systemic lupus erythematosus (SLE),…

BenlystaBiosimilarsGlaxoSmithKlineHealthcareNeurologicalPharmaceuticalResearchUSA

Roche posts solid sales performance for first nine months of 2014

Roche posts solid sales performance for first nine months of 2014

16-10-2014

Swiss pharma major Roche this morning released its financials for the first nine months of 2014, showing…

Economy of SwitzerlandFinancialPharmaceuticalRocheSwitzerlandtrastuzumab

AbbVie board withdraws bid to acquire Shire

AbbVie board withdraws bid to acquire Shire

16-10-2014

Following takeover target Shire’s waiver of the three-day notice period, AbbVie said this morning that…

AbbVieIrelandMergers & AcquisitionsPharmaceuticalShireUSA

1 to 25 of 7074 results

Parexel

Parexel

Back to top